IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study
|2||Enrolling by invitation||
Mission is Remission®: How Can a Disease Self-management Website Change Care?
A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's Disease
† Study has passed its completion date and status has not been verified in more than two years.